SPONSORED CONTENT

An HIV diagnosis does not have the same meaning today as when the

SPONSORED CONTENT

Since its introduction in 1992, the 340B Program has vastly altered the pharmacy landscape. In these

SPONSORED CONTENT

Finance guys like myself often have the reputation of being unwilling to spend money. However, we can always be convinced to invest in activities

SPONSORED CONTENT by Tyler Curry-McGrath, Avita Pharmacy

A patient newly diagnosed with HIV can often feel as if the cards are stacked against them before they even

SPONSORED CONTENT by Jerry Buller

The challenges that ‘white bagging’ poses for patients and providers are gaining attention as more health plans mandate

SPONSORED CONTENT by Dr. LeeAnn Scheer, Caravan Health

Safety net facilities are celebrating the May 17 HRSA letters to six drug manufacturers affirming

SPONSORED CONTENT by Kristin Fox-Smith and William Wood, Visante

Those of us actively engaged in the 340B Program are well aware

SPONSORED CONTENT

By: Diana Sierra, MPH, VP, Contract Pharmacy Partnership & RVS Operations, Sentry Data Systems

For years, covered entities generated savings from

SPONSORED CONTENT by Ross Halsne

It’s becoming increasingly difficult for Covered Entities (CEs) to effectively manage their 340B pharmacy programs.  Often times understaffed relative to the task of handling the myriad of challenges that come with managing a 340B

25% – 35%
of a hospital’s contract pharmacy opportunity lies in referral prescriptions

There are several ways to enhance, boost, and optimize 340B savings. This white paper looks at how capturing referrals can benefit a covered entity’s